20.67500 EUR
0.235
1.12%
Last update Dec 18, 8:04 AM CET
Market closed
Day range
20.67500
20.67500
Previous close
20.91000
Open
20.67500
Access this stock data via API
Subscribe
Apellis Pharmaceuticals Inc.
20.68
0.24
1.12%

Statistics

Valuation metrics
Market cap
2.73B
Enterprise value
2.17B
Trailing P/E (ttm)
67.45
Forward P/E
-3.49
PEG ratio
-3.49
Price/Sales (ttm)
2.72
Price/Book (mrq)
7.75
Enterprise Value/Revenue
2.50
Enterprise Value/EBITDA
30.99
Overview
Shares outstanding
126.50M
Float
89.57M
Shares short
% Held by insiders
13.64%
% Held by institutions
103.93%
Average volume (10 days)
100
Average volume (90 days)
55
Price summary
52-Week low
13.88
52-Week high
32.81
52-Week change
-51.08 -368.0%
Beta
0.36
50-Day moving average
19.30
200-Day moving average
18.42
Financials
Fiscal year
Fiscal year ends
Dec 31, 2024
Most recent quarter (mrq)
Sep 30, 2025
Profitability
Profit margin
4.43%
Operating margin
48.67%
Operational effectiveness
Return on assets
5.13%
Return on equity
14.10%
Income statement
Revenue (ttm)
866.47M
Revenue per share (ttm)
8.09
Quarterly revenue growth (yoy)
133%
Gross profit (ttm)
515.80M
EBITDA
69.97M
Net income to common (ttm)
38.35M
Diluted EPS (ttm)
0.31
Quarterly earnings growth (yoy)
129.75%
Balance sheet
Total cash (mrq)
409.39M
Total cash per share (mrq)
3.80
Total debt (mrq)
405.25M
Total Debt/Equity (mrq)
118.50
Current ratio (mrq)
354.40%
Book value per share (mrq)
2.70
Cash flow
Cash flow statement
67.23M
Levered free cash flow (LFCF)
42.02M
Access /statistics data via our API — starting from the Pro plan.
Market closed

Exchange is currently closed
Main market opens in 4 hours 16 minutes

03:43
00:00
08:00
22:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 22:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).